These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Use of electronic tonometer to assess skin hardness in systemic sclerosis: a pilot cross-sectional study. Dugar M; Woolford R; Ahern MJ; Smith MD; Roberts-Thomson PJ Clin Exp Rheumatol; 2009; 27(3 Suppl 54):70. PubMed ID: 19796567 [No Abstract] [Full Text] [Related]
25. Skin sclerosis is only of limited value to identify SSc patients with severe manifestations--an analysis of a distinct patient subgroup of the German Systemic Sclerosis Network (DNSS) Register. Hanitsch LG; Burmester GR; Witt C; Hunzelmann N; Genth E; Krieg T; Lehmacher W; Melchers I; Meurer M; Müller-Ladner U; Schulze-Lohoff E; Becker M; Sunderkoetter C; ; Riemekasten G Rheumatology (Oxford); 2009 Jan; 48(1):70-3. PubMed ID: 19056798 [TBL] [Abstract][Full Text] [Related]
26. Healthy children have a significantly increased skin score assessed with the modified Rodnan skin score. Foeldvari I; Wierk A Rheumatology (Oxford); 2006 Jan; 45(1):76-8. PubMed ID: 16174648 [TBL] [Abstract][Full Text] [Related]
27. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors. Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619 [TBL] [Abstract][Full Text] [Related]
28. Measurement of skin elastic properties with a new suction device (II): systemic sclerosis. Ishikawa T; Tamura T J Dermatol; 1996 Mar; 23(3):165-8. PubMed ID: 8935626 [TBL] [Abstract][Full Text] [Related]
29. A longitudinal follow-up of hand involvement and activities of daily living in early systemic sclerosis. Sandqvist G; Hesselstrand R; Eberhardt K Scand J Rheumatol; 2009; 38(4):304-10. PubMed ID: 19296402 [TBL] [Abstract][Full Text] [Related]
30. Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis. Matsushita T; Hasegawa M; Hamaguchi Y; Takehara K; Sato S J Rheumatol; 2006 Feb; 33(2):275-84. PubMed ID: 16465658 [TBL] [Abstract][Full Text] [Related]
31. [Systemic sclerosis and scleroderma circumscripta--disturbances of selected serum parameters which are responsible for vascular changes and CD34 expression in involved skin]. Dziankowska-Bartkowiak B; Zebrowska A; Wagrowska-Danielewicz M; Kobos J; Waszczykowska E Przegl Lek; 2009; 66(12):1040-5. PubMed ID: 20514902 [TBL] [Abstract][Full Text] [Related]
32. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Tyndall AJ; Bannert B; Vonk M; Airò P; Cozzi F; Carreira PE; Bancel DF; Allanore Y; Müller-Ladner U; Distler O; Iannone F; Pellerito R; Pileckyte M; Miniati I; Ananieva L; Gurman AB; Damjanov N; Mueller A; Valentini G; Riemekasten G; Tikly M; Hummers L; Henriques MJ; Caramaschi P; Scheja A; Rozman B; Ton E; Kumánovics G; Coleiro B; Feierl E; Szucs G; Von Mühlen CA; Riccieri V; Novak S; Chizzolini C; Kotulska A; Denton C; Coelho PC; Kötter I; Simsek I; de la Pena Lefebvre PG; Hachulla E; Seibold JR; Rednic S; Stork J; Morovic-Vergles J; Walker UA Ann Rheum Dis; 2010 Oct; 69(10):1809-15. PubMed ID: 20551155 [TBL] [Abstract][Full Text] [Related]
33. Clinical significance of serum hyaluronan levels in systemic sclerosis: association with disease severity. Yoshizaki A; Iwata Y; Komura K; Hara T; Ogawa F; Muroi E; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S J Rheumatol; 2008 Sep; 35(9):1825-9. PubMed ID: 18688912 [TBL] [Abstract][Full Text] [Related]
34. Elevated vascular endothelial growth factor in systemic sclerosis. Choi JJ; Min DJ; Cho ML; Min SY; Kim SJ; Lee SS; Park KS; Seo YI; Kim WU; Park SH; Cho CS J Rheumatol; 2003 Jul; 30(7):1529-33. PubMed ID: 12858453 [TBL] [Abstract][Full Text] [Related]
35. Correlation of serum collagen I carboxyterminal telopeptide concentrations with cutaneous and pulmonary involvement in systemic sclerosis. Allanore Y; Borderie D; Lemaréchal H; Cherruau B; Ekindjian OG; Kahan A J Rheumatol; 2003 Jan; 30(1):68-73. PubMed ID: 12508392 [TBL] [Abstract][Full Text] [Related]
36. Digital thermal hyperaemia impairment does not relate to skin fibrosis or macrovascular disease in systemic sclerosis. Salvat-Melis M; Carpentier PH; Minson CT; Boignard A; McCord GR; Paris A; Moreau-Gaudry A; Cracowski JL Rheumatology (Oxford); 2006 Dec; 45(12):1490-6. PubMed ID: 16705051 [TBL] [Abstract][Full Text] [Related]
37. [Plasmapheresis therapy in systemic sclerosis]. Szúcs G; Szamosi S; Aleksza M; Veres K; Soltész P Orv Hetil; 2003 Nov; 144(45):2213-7. PubMed ID: 14686006 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of caspase 1 and sFas serum levels in patients with systemic sclerosis: correlation with lung dysfunction, joint and bone involvement. Dziankowska-Bartkowiak B; Waszczykowska E; Zalewska A; Sysa-Jedrzejowska A Mediators Inflamm; 2003 Dec; 12(6):339-43. PubMed ID: 14668093 [TBL] [Abstract][Full Text] [Related]
39. [A case of progressive systemic sclerosis (PSS) without scleroderma]. Nagase T; Okudaira H; Komuro K; Yoshida K; Moroi Y; Mitamura T; Miyamoto T Ryumachi; 1985 Sep; 25(4):292-6. PubMed ID: 4081910 [No Abstract] [Full Text] [Related]
40. Correlation of endostatin and tissue inhibitor of metalloproteinases 2 (TIMP2) serum levels with cardiovascular involvement in systemic sclerosis patients. Dziankowska-Bartkowiak B; Waszczykowska E; Zalewska A; Sysa-Jedrzejowska A Mediators Inflamm; 2005 Aug; 2005(3):144-9. PubMed ID: 16106100 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]